Showing results (41-50 of 3,361) with videos related to
Sort By:
Pageof 337
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacinA L Barry, P C FuchsJournal of Chemotherapy (Florence, Italy)|February 1, 1997
Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacinA L Barry, P C FuchsJournal of Clinical Microbiology|October 1, 1996
Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniaeA L Barry, P C FuchsThe American Journal of Medicine|March 22, 1993
Selection of a fluoroquinolone-class disk for susceptibility testsA L Barry, P C FuchsAntimicrobial Agents and Chemotherapy|January 1, 1995
In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensA L Barry, P C FuchsJournal of Clinical Microbiology|November 1, 1994
Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acidP C Fuchs, A L BarryAntimicrobial Agents and Chemotherapy|April 1, 1976
Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methodsR N Jones, P C FuchsAmerican Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.Pageof 337